Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | IDXX | Restricted Stock Unit | Award | $0 | +208 | $0.00 | 208 | Sep 1, 2023 | Common Stock | 208 | Direct | F1, F2 | ||
transaction | IDXX | Non-Qualified Stock Option (right-to-buy) | Award | $0 | +493 | $0.00 | 493 | Sep 1, 2023 | Common Stock | 493 | $511.29 | Direct | F1, F3 |
Id | Content |
---|---|
F1 | This equity grant represents pro rata equity compensation earned by the reporting person as a non-employee Director from her election to the IDEXX Laboratories, Inc. Board of Directors on July 11, 2023 until the 2024 annual meeting of stockholders. |
F2 | Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. Restricted stock units vest in one installment on the date of the 2024 annual meeting of stockholders or May 17, 2024, whichever event occurs earlier. |
F3 | Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vests in one installment on May 17, 2024 or on the date of the 2024 annual meeting of stockholders, whichever event is earlier. |